Skip to the main content.

Newsroom

BVBA_KBI-2

Press Release | KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market

KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market

Read More
KBI Logo

Press Release | ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development

ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development

Read More
KBI_Logo

Press Release | KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities

KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities

Read More

Press Release | KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities

KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities

Read More

Press Release | JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.

JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.

Read More

Press Release | JSR Life Sciences Expands Manufacturing Capabilities at KBI Biopharma

JSR Life Sciences Expands Manufacturing Capabilities at KBI Biopharma

Read More

KBI Biopharma and BriaCell Therapeutics Corp. Enter Cell Therapy Manufacturing Agreement for BriaVax™ Cancer Vaccine

KBI Biopharma and BriaCell Therapeutics Corp. Enter Cell Therapy Manufacturing Agreement for BriaVaxTM Cancer Vaccine

Read More

KBI Biopharma Expands Its Services to Include Cell Therapy Manufacturing, Acquires Houston Area Facility

KBI Biopharma Expands Its Services to Include Cell Therapy Manufacturing, Acquires Houston Area Facility

Read More

Press | ​Accelerating Timelines Vital to Securing Slice of Biosimilars Market, KBI

Accelerating timelines vital to securing slice of biosimilars market, KBI

Read More

GlycoSeLect Announces Investment & Development Partnership with KBI Biopharma

15th August, 2016. Equity investment in initial funding round, license agreement and development project. Dublin, Ireland & Durham, North Carolina,...

Read More

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.